Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARTS-SAFE: Anakinra for Futile Reperfusion Following Endovascular Treatment in Acute Ischemic Stroke
NCT07423975Phase 2Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Apr 2026
- Primary completion
- Oct 2026
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of anakinra in ischemic stroke, sponsored by Beijing Tiantan Hospital. Started Apr 2026; status: recruiting.
02
Drugs
anakinra
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07423975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07423975.